Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

This funding opportunity supports a 3-year renewal of the COPE-AKI clinical trial consortium to meet enrollment targets, complete participant follow-up, and finalize data analysis and dissemination. The research focuses on improving clinical management and establishing standard care for Stage 2 and 3 acute kidney injury survivors through rigorous clinical trial activities.

Only the current recipient organization of the COPE-AKI Consortium under RFA-DK-20-012 is eligible to apply. Foreign organizations and foreign components of U.S. organizations are not eligible.